FDA Panel Struggles to Agree on Effectiveness of Tumor Device March 18, 2011 By U.S. Food & Drug Administration SOURCE
Catching up with Dr. Tom Oxley as Synchron builds toward a pivotal trial for FDA approval of its Stentrode BCI